Literature DB >> 16326301

pKa of fentanyl varies with temperature: implications for acid-base management during extremes of body temperature.

Richard L Thurlkill1, David A Cross, J Martin Scholtz, C Nick Pace.   

Abstract

OBJECTIVE: The pKa of fentanyl has not been measured previously at varying extremes of body temperature. The goal of this laboratory investigation was to test the hypothesis that the pKa of fentanyl changes with temperature.
DESIGN: The investigation involved measuring the pKa values of aqueous fentanyl at varying temperatures.
SETTING: The investigation was conducted in a controlled laboratory environment. PARTICIPANTS: No human or animal subjects were involved.
INTERVENTIONS: Because no live subjects were involved in the investigation, no interventions were necessary.
MEASUREMENTS AND MAIN RESULTS: This paper reports the effect of temperature on the pKa of fentanyl. The pKa of aqueous fentanyl was measured at 15 degrees C, 25 degrees C, 37 degrees C, 42 degrees C, and 47.5 degrees C by potentiometric titration in 0.01 mmol/L of potassium chloride after extensive degassing. Data were analyzed using the least squares method with an appropriately fitting equation. The pKa of fentanyl was found to change in a similar manner to the neutral point of water at varying temperatures.
CONCLUSIONS: This finding has implications for the bioavailability of fentanyl at extremes of body temperature in association with the clinical acid-base management of the patient. Clinical implications for differing methods of intraoperative acid-base management at varying temperatures are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16326301     DOI: 10.1053/j.jvca.2004.11.039

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  7 in total

Review 1.  Pharmacokinetics of non-intravenous formulations of fentanyl.

Authors:  Jörn Lötsch; Carmen Walter; Michael J Parnham; Bruno G Oertel; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

2.  Development of Methods for the Determination of pKa Values.

Authors:  Jetse Reijenga; Arno van Hoof; Antonie van Loon; Bram Teunissen
Journal:  Anal Chem Insights       Date:  2013-08-08

3.  pKa of opioid ligands as a discriminating factor for side effects.

Authors:  Giovanna Del Vecchio; Dominika Labuz; Julia Temp; Viola Seitz; Michael Kloner; Roger Negrete; Antonio Rodriguez-Gaztelumendi; Marcus Weber; Halina Machelska; Christoph Stein
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

4.  How μ-opioid receptor recognizes fentanyl.

Authors:  Quynh N Vo; Paween Mahinthichaichan; Jana Shen; Christopher R Ellis
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

5.  Opioid receptor signaling, analgesic and side effects induced by a computationally designed pH-dependent agonist.

Authors:  Viola Spahn; Giovanna Del Vecchio; Antonio Rodriguez-Gaztelumendi; Julia Temp; Dominika Labuz; Michael Kloner; Marco Reidelbach; Halina Machelska; Marcus Weber; Christoph Stein
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

6.  Internalized GPCRs as Potential Therapeutic Targets for the Management of Pain.

Authors:  Jeffri S Retamal; Paulina D Ramírez-García; Priyank A Shenoy; Daniel P Poole; Nicholas A Veldhuis
Journal:  Front Mol Neurosci       Date:  2019-11-12       Impact factor: 5.639

Review 7.  Electroanalysis of Fentanyl and Its New Analogs: A Review.

Authors:  Marta Katarzyna Choińska; Ivana Šestáková; Vojtěch Hrdlička; Jana Skopalová; Jan Langmaier; Vítězslav Maier; Tomáš Navrátil
Journal:  Biosensors (Basel)       Date:  2022-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.